DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial
Open Access
- 28 February 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 18 (4), 515-524
- https://doi.org/10.1016/s1470-2045(17)30154-7
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology GroupJournal of Clinical Oncology, 2016
- Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcomeHaematologica, 2015
- Acute Lymphoblastic Leukemia in ChildrenNew England Journal of Medicine, 2015
- Negative feedback–defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALLNature Medicine, 2015
- Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemiaNature Communications, 2015
- Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemiaNature Genetics, 2013
- Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemiaLeukemia, 2009
- Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancerNature Reviews Cancer, 2008
- Outcome After Relapse Among Children With Standard-Risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study CCG-1952Journal of Clinical Oncology, 2007
- Six Months of Maintenance Chemotherapy After Intensified Treatment for Acute Lymphoblastic Leukemia of ChildhoodJournal of Clinical Oncology, 2000